Market Overview

The market’s growth is being driven primarily by two factors: the rising demand for drug delivery devices that are both efficient and user-friendly, and the efforts of healthcare professionals to decrease hospital errors. During the forecast period, the market is anticipated to benefit from technologically advanced and feature-rich devices that provide safer and more convenient self-injections for patients, as well as the impact of COVID-19.

The industry’s expansion is also expected to be fueled by the rapid growth of biologic therapies. Therapeutic vaccines and other biologic drugs are becoming increasingly popular due to their superior efficacy, safety, and fewer side effects compared to traditional therapies. This development has created a need for innovative packaging solutions that can maintain the potency of biologic drugs, which are highly unstable.

Prefilled syringes are considered the best option for storing such drugs, as over 60% of biologic drugs in the pipeline are parenterally administered and vulnerable to deterioration from food and digestive enzymes. The prefilled syringes market is further benefited by the growth of the biologic drug market.

Segment Overview

The Prefilled Syringes market is categorized based on Material and Type. Material segmentation comprises Baked Silicone Syringes, Oil Siliconized Syringes, Glass Syringes, and Plastic Syringes, with the glass syringes segment holding the largest market share in 2022. Glass syringes are preferred in the industry because of their clearness and inertness, which make them a dependable option for ensuring the purity of dosage.

However, the rising demand for safer products that allow for self-administration of medicine and the fragility of glass syringes during transportation may limit their use.

The Type segmentation consists of Safety Prefilled Syringes and Conventional Prefilled Syringes. In 2022, the Safety Prefilled Syringes segment dominated market growth and is projected to be the fastest-growing segment from 2022-2030. The growth of this segment can be attributed to the increasing elderly population globally, the development of biological medicines for chronic diseases, and the outsourcing of low-risk medical procedures for chronic patients. This trend is expected to decrease the burden on hospitals.

Regional Analysis

Due to various reasons, Europe dominated the prefilled syringes market in 2021 in terms of geography. Healthcare professionals in the region favor prefilled injectable devices as they aid in reducing needle-related injuries. Furthermore, significant market participants such as Gerresheimer AG, SCHOTT group, Stevanato Group, Haselmeier AG, and Owen Mumford Ltd. are located in Europe and have built a robust foothold in the area over time. As a result, the market is consolidated, making it challenging for new entrants to penetrate.

Major Player

The companies holding significant positions in the market include AptarGroup Inc., SCHOTT AG, BD, Terumo Corporation, West Pharmaceutical Services Inc, Gerresheimer AG, Helvoet Rubber & Plastic Technologies B.V., and Nipro PharmaPackaging International Company.

COVID 19 Impacts

The global prefilled syringes market has been significantly impacted by the COVID-19 pandemic, with both positive and negative effects observed. The demand for prefilled syringes, particularly for vaccine administration, has witnessed a sharp rise due to the urgent need for mass vaccination during the pandemic. The development and distribution of COVID-19 vaccines have played a pivotal role in managing and controlling the disease.

However, the pandemic has also adversely affected the prefilled syringes market, leading to supply chain disruptions, reduced availability of the workforce, and reduced funding for research and development activities. This has resulted in delays in product delivery and impeded the growth of the market. Additionally, shutdowns of manufacturing facilities and restrictions on trade and transportation have further compounded the challenges faced by the market.

The COVID-19 pandemic has also highlighted the need for innovation in the prefilled syringes market to address issues such as storage and transportation. This has opened up new opportunities for market players to introduce new technologies and products to meet the rising demand for safe and effective vaccine delivery systems.

TABLE OF CONTENT

1 REPORT PROLOGUE
2 INTRODUCTION
2.1 DEFINITION 17
2.2 SCOPE OF THE STUDY 17
2.3 RESEARCH OBJECTIVE 17
2.4 ASSUMPTIONS & LIMITATIONS 17
2.4.1 ASSUMPTIONS 17
2.4.2 LIMITATIONS 17
2.5 MARKET STRUCTURE 17
3 RESEARCH METHODOLOGY
3.1 PRIMARY RESEARCH METHODOLOGY 19
3.2 SECONDARY RESEARCH METHODOLOGY 21
3.3 MARKET SIZE ESTIMATION 22
3.4 FORECAST MODEL 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 24
4.2 DRIVERS 25
4.2.1 HIGH PREVALENCE OF CHRONIC DISEASES 25
4.2.2 TECHNOLOGICAL ADVANCEMENTS 25
4.3 RESTRAINTS 25
4.3.1 PRODUCT RECALLS 25
4.4 CHALLENGE 25
4.4.1 STRINGENT REGULATIONS 25
4.5 MEGA TREND 26
4.5.1 TECHNOLOGICAL TRENDS 26
4.6 MACROECONOMICS 26
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 28
5.1.1 BARGAINING POWER OF SUPPLIERS 28
5.1.2 BARGAINING POWER OF BUYERS 29
5.1.3 THREAT OF NEW ENTRANTS 29
5.1.4 THREAT OF SUBSTITUTES 29
5.1.5 INTENSITY OF RIVALRY 29
5.2 VALUE CHAIN ANALYSIS 30
5.2.1 R&D 30
5.2.2 MANUFACTURING 30
5.2.3 DISTRIBUTION & SALES 30
5.2.4 POST-SALES MONITORING 31
5.3 DEMAND & SUPPLY: GAP ANALYSIS 31
5.4 PRICING ANALYSIS 31
6 PREFILLED SYRINGES MARKET, BY MATERIAL
6.1 INTRODUCTION 33
6.2 GLASS PREFILLED SYRINGES 35
6.2.1 OIL SILICONISED SYRINGES 35
6.2.2 BAKED ON SILICONE SYRINGES 36
6.3 PLASTIC SYRINGES 36
7 PREFILLED SYRINGES MARKET, BY TYPE
7.1 INTRODUCTION 38
7.2 CONVENTIONAL PREFILLED SYRINGES 39
7.3 SAFETY PREFILLED SYRINGES 39
8 PREFILLED SYRINGES MARKET, BY DESIGN
8.1 INTRODUCTION 41
8.2 SINGLE-CHAMBER PREFILLED SYRINGES 42
8.3 DUAL-CHAMBER PREFILLED SYRINGES 42
8.4 CUSTOMIZED PREFILLED SYRINGES 42
9 PREFILLED SYRINGES MARKET, BY END USER
9.1 INTRODUCTION 44
9.2 HOSPITALS/CLINICS 45
9.3 AMBULATORY SURGICAL CENTER 45
10 GLOBAL PREFILLED SYRINGES, BY REGION
10.1 INTRODUCTION 47
10.2 EUROPE 48
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1 WESTERN EUROPE 51
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1.1 GERMANY 53
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1.2 FRANCE 54
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1.3 UK 55
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1.4 ITALY 57
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1.5 SPAIN 58
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.1.6 REST OF WESTERN EUROPE 60
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.2.2 EASTERN EUROPE 61
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.3 AMERICAS 64
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.3.1 NORTH AMERICA 67
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.3.1.1 US. 70
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.3.1.2 CANADA 71
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.3.2 SOUTH AMERICA 72
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4 ASIA-PACIFIC 74
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4.1 JAPAN 76
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4.2 CHINA 78
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4.3 INDIA 79
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4.4 AUSTRALIA 81
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4.5 SOUTH KOREA 83
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.4.6 REST OF ASIA-PACIFIC 86
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.5 MIDDLE EAST & AFRICA 88
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.5.1 MIDDLE EAST 91
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
10.5.2 AFRICA 93
PREFILLED SYRINGES MARKET, BY MATERIAL
PREFILLED SYRINGES MARKET, BY TYPE
PREFILLED SYRINGES MARKET, BY DESIGN
PREFILLED SYRINGES MARKET, BY END USER
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 96
12 COMPANY PROFILES
12.1 GERRESHEIMER AG 98
12.1.1 COMPANY OVERVIEW 98
12.1.2 FINANCIAL OVERVIEW 98
12.1.3 PRODUCTS OFFERED 99
12.1.4 KEY DEVELOPMENTS 99
12.1.5 SWOT ANALYSIS 99
12.1.6 KEY STRATEGIES 99
12.2 SCHOTT AG 100
12.2.1 COMPANY OVERVIEW 100
12.2.2 FINANCIAL OVERVIEW 100
12.2.3 PRODUCTS OFFERED 101
12.2.4 KEY DEVELOPMENTS 101
12.2.5 SWOT ANALYSIS 101
12.2.6 KEY STRATEGIES 101
12.3 MEDTRONIC 102
12.3.1 COMPANY OVERVIEW 102
12.3.2 FINANCIAL OVERVIEW 102
12.3.3 PRODUCTS OFFERED 103
12.3.4 KEY DEVELOPMENTS 103
12.3.5 SWOT ANALYSIS 103
12.3.6 KEY STRATEGIES 103
12.4 TERUMO CORPORATION 104
12.4.1 COMPANY OVERVIEW 104
12.4.2 FINANCIAL OVERVIEW 104
12.4.3 PRODUCTS OFFERED 105
12.4.4 KEY DEVELOPMENTS 105
12.4.5 SWOT ANALYSIS 105
12.4.6 KEY STRATEGIES 105
12.5 ABBOTT 106
12.5.1 COMPANY OVERVIEW 106
12.5.2 FINANCIAL OVERVIEW 106
12.5.3 PRODUCTS OFFERED 106
12.5.4 KEY DEVELOPMENTS 107
12.5.5 SWOT ANALYSIS 107
12.5.6 KEY STRATEGIES 107
12.6 NIPRO CORPORATION 108
12.6.1 COMPANY OVERVIEW 108
12.6.2 FINANCIAL OVERVIEW 108
12.6.3 PRODUCTS OFFERED 109
12.6.4 KEY DEVELOPMENTS 109
12.6.5 SWOT ANALYSIS 109
12.6.6 KEY STRATEGIES 109
12.7 BAXTER 110
12.7.1 COMPANY OVERVIEW 110
12.7.2 FINANCIAL OVERVIEW 110
12.7.3 PRODUCTS OFFERED 111
12.7.4 KEY DEVELOPMENTS 111
12.7.5 SWOT ANALYSIS 111
12.7.6 KEY STRATEGIES 111
12.8 BECTON, DICKINSON AND COMPANY 112
12.8.1 COMPANY OVERVIEW 112
12.8.2 FINANCIAL OVERVIEW 112
12.8.3 PRODUCTS OFFERED 113
12.8.4 KEY DEVELOPMENTS 113
12.8.5 SWOT ANALYSIS 113
12.8.6 KEY STRATEGIES 113
12.9 WEST PHARMACEUTICAL 114
12.9.1 COMPANY OVERVIEW 114
12.9.2 FINANCIAL OVERVIEW 114
12.9.3 PRODUCTS OFFERED 115
12.9.4 KEY DEVELOPMENTS 115
12.9.5 SWOT ANALYSIS 115
12.9.6 KEY STRATEGIES 115
12.10 WEIGAO GROUP 116
12.10.1 COMPANY OVERVIEW 116
12.10.2 FINANCIAL OVERVIEW 116
12.10.3 PRODUCTS OFFERED 117
12.10.4 KEY DEVELOPMENTS 117
12.10.5 SWOT ANALYSIS 117
12.10.6 KEY STRATEGIES 117
12.11 VETTER PHARMA INTERNATIONAL GMBH 118
12.11.1 COMPANY OVERVIEW 118
12.11.2 FINANCIAL OVERVIEW 118
12.11.3 PRODUCTS OFFERED 118
12.11.4 KEY DEVELOPMENTS 118
12.11.5 SWOT ANALYSIS 118
12.11.6 KEY STRATEGIES 119
12.12 OMPI (A STEVANATO GROUP COMPANY) 120
12.12.1 COMPANY OVERVIEW 120
12.12.2 FINANCIAL OVERVIEW 120
12.12.3 PRODUCTS OFFERED 120
12.12.4 KEY DEVELOPMENTS 120
12.12.5 SWOT ANALYSIS 120
12.12.6 KEY STRATEGIES 120
13 CONCLUSION
13.1 KEY FINDINGS 122
13.1.1 CEO’S VIEWPOINT 122
13.1.2 UNMET NEEDS 122
13.1.3 KEY COMPANIES TO WATCH 122
13.1.4 PREDICTION OF THE PREFILLED SYRINGES INDUSTRY 122
14 APPENDIX
14.1 DISCUSSION BLUE PRINT 124
14.2 RECENT KEY DEVELOPMENTS 125
14.3 REFERENCES 125

The post Prefilled Syringe Market Forecast till 2030 first appeared on CRI Report.